CATALYST PHARMACEU earnings per share and revenue

CN2 earnings per share for the last quarter are 0.17 CHF whereas the estimation was 0.18 CHF which accounts for -4.20% surprise. Company revenue for the same period amounts to 88.81 M CHF despite the estimated figure of 89.11 M CHF. Estimated earnings per share for the next quarter are 0.25 CHF, and revenue is expected to reach 101.91 M CHF. Also watch annual changes over time to get a bigger picture of CN2 earnings per share and revenue dynamics.